Antioxidant therapy and cardiovasculardisorders

Bibliography

• BERLINER JA, NAVAB M, FOGELMAN AM et al: Athero-: basic mechanisms. Oxidation, inflammation genetics. Circulation (1995) 91 (9):2488–2496.
   PubMed Web of Science ®Google Scholar
• •A detailed review on the basic mechanisms of atherogenesis.
   Google Scholar
• PANNALA AS, RICE-EVANS C, SAMPSON J, SINGH S: of peroxynitrite with carotenoids and tocopherols within low density lipoprotein. FEBS Lett. (1998) 423(3):297–301.
   PubMedGoogle Scholar
• HADAR DP, HABERLAND ME: lipoprotein trafficking in vascular cells. J. Biol. Chem. (1997) 272 (37):22975–22978.
   PubMedGoogle Scholar
• DRAKE TA, HANNANI K, FEI HH, LAVI S, BERLINER JA: Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothe-lial cells. Am. J. Pathol (1991) 138(3):601–607.
   PubMed Web of Science ®Google Scholar
• FEI H, BERLINER JA, DRAKE TA: Regulation of endothe-lial cell tissue factor expression by minimally oxidized LDL and lip op olysacch aride. Arterioscler. Thromb. (1993) 13(10:1711–1717.
   PubMedGoogle Scholar
• LATRON Y, CHAUTAN M, ANFOSSO F et al.: Stimulating effect of oxidized low density lipoproteins on plasmi-nogen activator inhibitor-1 synthesis by endothelial cells. Arterioscler. Thromb. (1991) 11 (6):1821–1829.
   PubMedGoogle Scholar
• FUSTER V, Lewis A: Conner Memorial Lecture.Mechanisms leading to myocardial infraction: insights from studies of vascular biology. Circulation (1994) 90(02126–2146
   Google Scholar
• HALLIWELL B, GUTTERIDGE JMC: Free radicals, ageing and disease. In: Free radicals in biology and medicine. Halliwell B, Gutteridge JMC (Eds.), Oxford University Press, Oxford, UK (1990:416–508.
   Google Scholar
• ••An excellent book about the biology and pathophysiologyconcerning free radicals.
   Google Scholar
• BROWN MS, GOLDSTEIN JL: Atherosclerosis.Scavenging for receptors. Nature (1990) 343 (6258)508–509.
   Google Scholar
• FREEMAN M, ASHKENAS J, REES DJ et al.: An ancient,highly conserved family of cysteine-rich protein domain revealed by cloning Type land Type II murine macrophage scavenger receptors. Proc. Nati Acad. Sci. USA (1990) 87(22):8810–8814.
   PubMedGoogle Scholar
• SPARROW CP, PARTHASARATHY S, STEINBERG D: A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J. Biol. Chem. (1989) 264(5):2599–2604.
   PubMedGoogle Scholar
• ROSS R: The pathogenesis of atherosclerosis: aperspective for the 1990s. Nature (1993) 362(6423)801–809.
   Google Scholar
• KU G, THOMAS CE, AKESON AL, JACKSON RL: Inductionof interleukin 1 beta expression from human periph-eral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. (1992) 267(2014183–14188.
   Google Scholar
• QUINN MT, PARTHASARATHY S, STEINBERG D: Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in athero-gen esis. Proc. Natl. Acad. Sci. USA (1988) 85 (8) : 2805–2809.
   PubMedGoogle Scholar
• MCMURRAY HF, PARTHASARATHY S, STEINBERG D: Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. din. Invest. (1993) 92(2):1004–1008.
   PubMed Web of Science ®Google Scholar
• KUME N, CYBULSKY MI, GIMBRONE MA Jr: Lysophos-phatidylcholine, a component of atherogenic lipopro-teins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. (1992) 90 (3) :1138–1144 .
   PubMed Web of Science ®Google Scholar
• COLLES SM, IRWIN KC, CHISOLM GM: Roles of multipleoxidised LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol. J. Lipid Res. (1996) 37 (9):2018–2028.
   PubMed Web of Science ®Google Scholar
• AUPEIX K, WELTIN D, MEJIA JE et al.: Oxysterol-inducedapoptosis in human monocytic cell lines. Immuno-biology (1995) 194 (4-5):415–428.
   PubMedGoogle Scholar
• REKKA E, MANNHOLD RM, BAST A, TIMMERMAN H: Molecular pharmacological aspects of antiarrhythmic activity I. Class I and class III compounds and lipid peroxidation. Biochem. Pharmacol (1990) 39:95–100.
   Google Scholar
• BECKMAN JS, KOPPENOL WH: Nitric oxide, superoxide peroxinitrite: the good, the bad and the ugly. Am]. Physic)]. (1996) 271(5 Pt 1):C424–437.
   Google Scholar
• •Good review on the chemistry and biology of NO.
   Google Scholar
• IGNARRO LJ, BYRNS RE, BUGA GM, WOOD KS: Endothelium-derived relaxing factor from pulmonary artery and vein possess pharmacologic and chemical properties identical to those of nitric oxide radical. Circ. Res. (1987) 61:866–879.
   PubMed Web of Science ®Google Scholar
• ••A historical article on the identification of the biologic role ofNO.
   Google Scholar
• FURCHGOTT RF, ZAWADZKI JV: The obligatory role of cells in the relaxation of arterial smooth muscle by acetylocholine. Nature (1980) 288:373–376.
   PubMed Web of Science ®Google Scholar
• ••A historical article on the role of EDRF.
   Google Scholar
• EBERHARDT RT, LOSCALZO J: Nitric oxide in atheroscle-. In: Nitric oxide and the cardiovascular system. Loscalzo J, Vita JA (Eds.), Humana Press, New Jersey, USA (2000):273–295.
   Google Scholar
• •A detailed book chapter on the role of NO in atherosclerosis.
   Google Scholar
• BUSSE R, MOLSCH A, FLEMING I, HECKER M:Mechanisms of nitric oxide release from vascular endothelium. Circulation. (1993) 87:V18–V25.
   Web of Science ®Google Scholar
• WARE JA, HEISTAD DD: Seminars in medicine of theBeth Israel Hospital, Boston. Platelet-endothelium interactions. N Engl. J. Med. (1993) 328(9):628–635.
   PubMedGoogle Scholar
• MELLION BT, IGNARRO LJ, OHLSTEIN EH et al.: Evidencefor the inhibitory role of g-uanosine 3', 5'-monopho-sphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood (1981) 57(5):946–955.
   PubMedGoogle Scholar
• MENDELSOHN ME, ONEILL S, GEORGE D, LOSCALZO J:Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcystein. J. Biol. Chem. (1990) 265 (3 1) :19028–19034.
   Google Scholar
• RADOMSKI MW, PALMER RM, MONCADA S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Nati Acad. ScL USA (1990) 87(13): 5193–5197.
   PubMed Web of Science ®Google Scholar
• VASTA V, MEACCI E, FARNARARO M, BRUNI P: Identifica-tion of a specific transport system for L-arginine in human platelets. Biochem. Biophys. Res. Commun. (1995) 206:878–884.
   PubMedGoogle Scholar
• TSAO PS, LEWIS NP, ALPERT S, COOKE JP: Exposure toshear stress alters endothelial adhensiveness. Role of nitric oxide. Circulation (1995) 92(12):3513–3519.
   Google Scholar
• KEANEY JF, JR., VITA JA: Atherosclerosis, oxidativestress and antioxidant protection in endothelium-derived relaxing factor action. Prog. Cardiovasc. Dis. (1995) 38 (2) :129–154.
   PubMed Web of Science ®Google Scholar
• HOGG N, KALYANARAMAN B, JOSEPH J, SRTUCK A, PARTHASARATHY S: Inhibition of low-density lipopro-tein oxidation by nitric oxide: potential role in athero-genesis. FEBS Lett. (1993) 334:170–174.
   PubMed Web of Science ®Google Scholar
• GUTTERIDGE JM, HALLIWELL B: Free radicals and in the year 2000. A historical look to the future. Ann. NY Acad. Sci. (2000) 899:136–147.
   PubMed Web of Science ®Google Scholar
• ••Interesting review highlighting the interrelationships of freeradicals and antioxidants of the body in health and disease.
   Google Scholar
• KUROWSKA EM, CARROLL KK: Hypocholesterolemic properties of nitric oxide. In vivo and in vitro studies using nitric oxide donors. Biochim. Biophys. Acta (1998) 1932 (1) :41–50.
   Google Scholar
• •Describes the influence of NO on LDLs.
   Google Scholar
• VISIOLI F, KEANEY JF, HALLIWELL B: Antioxidants and cardiovascular disease; panaceas or tonics for tired sheep? Cardiovasc. Res. (2000) 47(3):409.
   Google Scholar
• HALLIWELL B: Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc. Res. (2000) 47 (3):410–418.
   Google Scholar
• ••Excellent review on the impact and prospects for the futureof free radicals and antioxidants on cardiovascular disease.
   Google Scholar
• OHARA Y, PETERSON TE, HARRISON DG: Hypercholes-terolemia increases endothelial superoxide anion production. J. din. Invest. (1993) 91 (6):2546–2551.
   PubMed Web of Science ®Google Scholar
• PRASAD K, KALRA J: Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E Am. Heart J (1993) 125 (4):958–973.
   PubMed Web of Science ®Google Scholar
• PRASAD K: Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol digluco side isolated from flax-seed. Circulation (1999) 99(10):1355–1362.
   PubMed Web of Science ®Google Scholar
• PRASAD K: Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol. Cell Biochem. (1997) 168(1-2):117–123.
   PubMed Web of Science ®Google Scholar
• CHRYSSELIS MC, REKKA EA, KOUROUNAKIS PN: Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity. J. Med. Chem. (2000) 43 (4):609–612.
   PubMedGoogle Scholar
• ••New compounds with potent hypolipidaemic and antioxi-dant activity.
   Google Scholar
• KIM YS, PYO MK, PARK KM et al.: Antiplatelet and effects of a combination of ticlopidine and Ginkgo biloba ext (EGb761). Thromb. Res. (1998) 91 (1):33–38.
   PubMed Web of Science ®Google Scholar